Clinical Trial Update: Carboplatin/Taxol/Ridaforolimus in Endometrial, Ovarian and Solids [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating a combination of carboplatin, paclitaxel (Taxol), and ridaforolimus in endometrial and ovarian cancers; study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer
• Ovarian Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Ridaforolimus (ridaforolimus)
• Taxol (paclitaxel)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Endometrial Cancer, Ovarian Cancer | Phase 1 | Status: COMPLETED